Author Search Results :: Kabale University Library Catalog

1

$Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial$

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial by M. S. Brose, F. P. Worden, K. L. Newbold, M. Guo, A. Hurria

Published 2018-07-01

Get full text

Article

Save to List

Saved in:
2

Влияние прерывания терапии ленватинибом на общую эффективность лечения у пациентов с радиойодрезистентным дифференцированным раком щитовидной железы в исследовании III фазы... by M. Tahara, M. S. Brose, L. J. Wirth, T. Suzuki, H. Miyagishi, K. Fujino, C. E. Dutcus, A. Gianoukakis

Published 2019-04-01

Get full text

Article

Save to List

Saved in:
3

Лечение токсических побочных эффектов у пациентов с распространенным медуллярным раком щитовидной железы... by M. S. Brose, K. C. Bible, L. Q. M. Chow, J. Gilbert, C. Grande, F. Worden, R. Haddad

Published 2019-04-01

Get full text

Article

Save to List

Saved in:
4

$A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer$

A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer by M. S. Brose, Yu. Panaseykin, B. Konda, C. de la Fouchardiere, B. G.M. Hughes, A. G. Gianoukakis, Y. J. Park, I. Romanov, M. K. Krzyzanowska, S. Leboulleux, T. A. Binder, C. Dutcus, R. Xie, M. H. Taylor

Published 2022-04-01

Get full text

Article

Save to List

Saved in: